Skip to main navigation Skip to search Skip to main content

Innervation of dystrophic muscle after muscle stem cell therapy

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Introduction: Duchenne muscular dystrophy (DMD) is caused by loss of the structural protein, dystrophin, resulting in muscle fragility. Muscle stem cell (MuSC) transplantation is a potential therapy for DMD. It is unknown whether donor-derived muscle fibers are structurally innervated. Methods: Green fluorescent protein (GFP)–expressing MuSCs were transplanted into the tibials anterior of adult dystrophic mdx/mTR mice. Three weeks later the neuromuscular junction was labeled by immunohistochemistry. Results: The percent overlap between pre- and postsynaptic immunolabeling was greater in donor-derived GFP+ myofibers, and fewer GFP+ myofibers were identified as denervated compared with control GFP fibers (P = 0.001 and 0.03). GFP+ fibers also demonstrated acetylcholine receptor fragmentation and expanded endplate area, indicators of muscle reinnervation (P = 0.008 and 0.033). Conclusion: It is unclear whether GFP+ fibers are a result of de novo synthesis or fusion with damaged endogenous fibers. Either way, donor-derived fibers demonstrate clear histological innervation. Muscle Nerve 54: 763–768, 2016.

Original languageEnglish
Pages (from-to)763-768
Number of pages6
JournalMuscle and Nerve
Volume54
Issue number4
DOIs
StatePublished - Oct 1 2016

Keywords

  • Duchenne muscular dystrophy
  • denervation
  • muscle stem cell
  • neuromuscular junction
  • skeletal muscle

Fingerprint

Dive into the research topics of 'Innervation of dystrophic muscle after muscle stem cell therapy'. Together they form a unique fingerprint.

Cite this